logo
  • About
    • The Company
    • Our Heritage
    • Mission & Vision
    • Expertise
  • Services
    • Products
  • Investor relations
    • Financial Information
      • Annual Financials
        • FY18
        • FY19
        • FY20
        • FY21
        • FY22
      • Quarterly Results
        • Quarterly Results 21-22
          • Financial Results Q1(April- June)
          • Financial Results Q2(July- Sep)
          • Financial results Q3 (Oct- Dec)
          • Financial results Q4 (Jan- Mar)
        • Quarterly Results 22-23
          • Financial Results Q1(April- June)
          • Financial Results Q2(July-Sep)
          • Financial Results Q3(Oct-Dec)
          • Financial Results Q4 (Jan-Mar)
      • Investor Presentation
        • Result Presentation FY 21-22
          • Result Presentation Q1
          • Result Presentation Q2
          • Result Presentation Q3
          • Result Presentation Q4
        • Result Presentation FY 22-23
          • Q1 FY 22-23
          • Q2 FY 22-23
          • Q3 FY 22-23
          • Q4 FY 22-23
      • Quarterly results press release
      • Earnings Call Transcript
        • Audio Transcript
        • FY 21-22
          • Q1 FY22
          • Q2 FY22
          • Q3 FY22
          • Q4 FY22
        • FY 22-23
          • Q1
          • Q2
          • Q3
      • Annual Report
        • 21st AGM Transcript
        • FY 21-22
      • Buy Back of Shares
        • Public Announcement
        • Daily Reporting
        • Extinguishment of Shares
    • Corporate Governance
      • Committee Composition
      • LIST OF DIRECTORS
      • Independent Directors
        • Audit Committee Charter
        • CSR Committee Charter
        • Stakeholder Relationship Committee Charter
        • Nomination and Remuneration Committee Charter
        • Terms and Conditions for appointment of Independent Director
      • Management Team Information
      • Code of Conduct
      • Policies
      • Annual Return
        • Annual Return FY 20-21
        • Annual Return FY 21-22
      • Credit Rating
    • Investor information
      • Company Fact sheet
      • Shareholding Pattern
      • Stock Price
    • Corporate Announcements
      • Notice of Board Meeting
      • Invites and Others
      • Stock Exchange Communication
      • Certificate under Reg 74(5)
      • Monitoring Agency
      • Statement of Deviation
      • SECRETARIAL COMPLIANCE REPORT
      • Schedule of Analysts
      • PUBLISHED IN NEWSPAPER
    • Investor Contact
      • Compliance Officer
      • Investor Relations
      • Registrar
      • Grievance Officer
      • Contact for Material Events
  • CSR
  • Career
  • Contact
  • Search

Photo

This is a custom category page for Photo.

Centered Slides

Centered Stack Full-Width

About

The Company
Our Heritage
Mission & Vision
Leadership
Facilities

Expertise

Manufacturing
R & D
Quality
Regulatory

Services

Contract Manufacturing

Brands

Windlas Pharma

  • Career
  • CSR
  • Blog
  • Media
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Contact

© Copyrights 2021 Windlas. All rights reserved.

Start a conversation

Tel: 0124 282 1030
Tel: +91 135 6608000
Email: info@windlasbiotech.com,
grievance@windlasbiotech.com

Privacy Preference Center

Privacy Preferences